Dr. M. Vishwanath is a highly qualified Medical Oncologist with advanced training in Medical Oncology (DM), Internal Medicine (MD), and MBBS. He has extensive experience in diagnosing and treating a wide spectrum of cancers, including solid tumors, hematological malignancies, and pediatric cancers.
During his three years of specialized oncology training at Madras Medical College, he independently managed chemotherapy day-care services, inpatient oncology, oncology emergencies, and multidisciplinary cancer care. His expertise includes chemotherapy, targeted therapy, immunotherapy, supportive care, and palliative oncology.
Dr. Vishwanath believes in delivering evidence-based treatment with empathy, ensuring every patient receives personalized care throughout their cancer journey. His commitment to continuous learning, research, and compassionate patient care makes him a trusted oncology specialist.
Years of Oncology Experience
Chemotherapy Sessions Managed
Cancer Patients Treated
26 Jul 2026
Poster Presentation at Max Cancer Congress, Mumbai
Dr. M. Vishwanath presented a scientific poster on "Thiamine Deficiency in Cancer Patients" at the prestigious Max Cancer Congress in Mumbai. The presentation highlighted the importance of identifying nutritional deficiencies in oncology patients and emphasized strategies for early recognition.
Read more
26 Jul 2026
Speaker at Spotlight Bone Marrow Transplant Conference
Dr. M. Vishwanath was invited as a speaker at the Spotlight Bone Marrow Transplant (BMT) Conference, where he delivered an expert session on "Transplant in Mantle Cell Lymphoma." His presentation focused on current transplant strategies, patient selection, evolving treatment approaches.
Read more
26 Jul 2026
Research Presentation at ICON Conference
At the Indian Cooperative Oncology Network (ICON) Conference, Dr. M. Vishwanath presented his research paper on the "Demographic Profile of Pancreatic Neuroendocrine Tumors." The study explored patient demographics and clinical characteristics, contributing valuable insights into the understanding.
Read more
26 Jul 2026
Unmasking a Silent Threat: A Rare Case of Cardiac Angiosarcoma
The article highlights the diagnostic challenges associated with this rare condition, as its symptoms often resemble those of more common cardiac disorders, leading to delayed diagnosis.
Read more
S. Kumar
K K Nagar
Dr. Vishwanath explained every stage of my treatment clearly and made me feel confident throughout my chemotherapy. His compassionate approach and medical expertise gave me strength during a difficult time.
Lakshmi R.
Thillai Nagar
I truly appreciate the personalized care and attention I received. Dr. Vishwanath was always patient, supportive, and available whenever I had questions. His guidance made my cancer treatment journey much easier.
Priya S.
K K Nagar
From diagnosis to follow-up care, Dr. Vishwanath ensured I understood every step of my treatment. His reassuring nature and expertise gave me confidence throughout my recovery.
Mohan R.
Thillai Nagar
The entire team was supportive, and Dr. Vishwanath's treatment approach was both professional and compassionate. I always felt I was receiving the best possible care.
Anitha P
Srirangam
Dr. Vishwanath patiently answered all my questions and created a treatment plan tailored to my condition. I sincerely appreciate his dedication and care.
Dr. Vishwanath treats breast cancer, lung cancer, gastrointestinal cancers, blood cancers, gynecological cancers, genitourinary cancers, head & neck cancers, melanoma, and many other malignancies.
Yes. Comprehensive chemotherapy planning, administration, monitoring, and supportive care are provided.
Yes. Eligible patients can receive immunotherapy and targeted therapy based on their diagnosis and treatment plan.
No. Patients may book a consultation directly or come with a referral from another physician.
Please bring previous medical records, biopsy reports, pathology results, imaging studies, blood investigations, and current medications.
Yes. Dr. Vishwanath offers expert second opinions to help patients understand all available treatment options.
Yes. Comprehensive supportive care is offered to improve comfort, manage symptoms, and enhance quality of life.
Follow-up schedules are personalized based on your diagnosis, treatment plan, and recovery progress.
Yes. He has extensive experience in managing hematological cancers, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndrome (MDS), and chronic myeloid leukemia (CML).
Yes. He is skilled in performing bone marrow aspiration, bone marrow biopsy, intrathecal chemotherapy, and central venous line management, including PICC lines and chemoports.
Every treatment plan is personalized after reviewing the patient's medical history, diagnostic reports, cancer stage, overall health, and treatment goals. Patients are actively involved in discussing and choosing the most appropriate treatment options.
Yes. Along with cancer treatment, Dr. Vishwanath focuses on symptom management, pain relief, nutritional support, and palliative care to improve patients' comfort and quality of life throughout their treatment journey.
You can book an appointment by calling the clinic directly, using the online appointment form, or contacting the hospital where Dr. Vishwanath consults. Early appointments are recommended for timely evaluation and treatment planning.
Breast cancer treatment requires a personalized approach based on the stage of disease, tumor biology, hormone receptor status, and the patient's overall health.
Lung cancer management requires accurate diagnosis, careful staging, and individualized treatment planning.
Dr. M. Vishwanath offers specialized medical oncology care for gastrointestinal cancers, including cancers of the stomach, colon, rectum, pancreas, liver, esophagus, and biliary tract.
Bone marrow aspiration and biopsy are important diagnostic procedures used to evaluate blood disorders and hematological cancers such as leukemia, lymphoma, multiple myeloma, myelodysplastic syndrome.
Intrathecal chemotherapy is a specialized treatment used to deliver anticancer medication directly into the cerebrospinal fluid surrounding the brain and spinal cord.
